Here are five things to know about Ascension’s most recent financial results.
1. The revenue boost was attributable, in part, to an increase in patient volume. Ascension said outpatient visits, inpatient admissions and emergency room volume were up in the six-month period that ended Dec. 31.
2. Ascension said the increase in patient volume was primarily attributable to its acquisition of Glendale, Wis.-based Wheaton Franciscan Healthcare in March.
3. Ascension saw expenses rise 7.1 percent year over year to nearly $11 billion in the second half of last year. The increase was partially due to higher labor and supplies costs.
4. Ascension ended the second half of 2016 with an operating margin of 3.3 percent, up from an operating margin of 2.9 percent in the same period of the year prior.
5. The system recorded a net income of $795 million in the second half of 2016, compared to a net loss of $373 million in the same period of 2015.
More articles on healthcare finance:
Allina Health’s nursing strike costs reached $149M in 2016
North Tide Capital sells off entire stake in CHS
100 things to know about Medicare reimbursement | 2017
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
